Mento Steven J
Insider CIK 1324466 · SGMO Director · CNAT President, CEO & Director, Director · DRMA Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| DRMA Dermata Therapeutics, Inc. | A Award deriv | 2026-01-02 | 2026-01-06 | 2,500 | — | $0 | 2,500 | SEC↗ |
| DRMA Dermata Therapeutics, Inc. | A Award deriv | 2025-01-13 | 2025-01-14 | 5,000 | — | $0 | 5,000 | SEC↗ |
| DRMA Dermata Therapeutics, Inc. | A Award deriv | 2024-01-04 | 2024-01-05 | 10,000 | — | $0 | 10,000 | SEC↗ |
| HSTO Histogen Inc. | D To issuer deriv | 2023-03-10 | 2023-03-14 | 7,582 | — | $0 | 0 | SEC↗ |
| HSTO Histogen Inc. | A Award deriv | 2023-03-10 | 2023-03-14 | 158,055 | — | $0 | 158,055 | SEC↗ |
| HSTO Histogen Inc. | A Award deriv | 2023-03-10 | 2023-03-14 | 55,532 | — | $0 | 55,532 | SEC↗ |
| HSTO Histogen Inc. | D To issuer deriv | 2023-03-10 | 2023-03-14 | 18,892 | — | $0 | 0 | SEC↗ |
| HSTO Histogen Inc. | D To issuer deriv | 2022-11-07 | 2022-11-09 | 11,419 | $250.00 | $2.85M | 0 | SEC↗ |
| HSTO Histogen Inc. | A Award deriv | 2022-02-24 | 2022-02-25 | 151,642 | — | $0 | 151,642 | SEC↗ |
| DRMA Dermata Therapeutics, Inc. | A Award deriv | 2022-01-03 | 2022-01-05 | 5,000 | — | $0 | 5,000 | SEC↗ |
| HSTO Histogen Inc. | A Award deriv | 2021-11-08 | 2021-11-10 | 228,395 | — | $0 | 228,395 | SEC↗ |
| HSTO Histogen Inc. | A Award deriv | 2021-11-08 | 2021-11-10 | 377,830 | — | $0 | 377,830 | SEC↗ |
| HSTO Histogen Inc. | A Award deriv | 2021-09-02 | 2021-09-03 | 20,000 | — | $0 | 20,000 | SEC↗ |
| DRMA Dermata Therapeutics, Inc. | A Award deriv | 2021-08-17 | 2021-08-17 | 10,000 | — | $0 | 10,000 | SEC↗ |
| HSTO Histogen Inc. | A Award deriv | 2020-10-07 | 2020-10-09 | 20,000 | — | $0 | 20,000 | SEC↗ |
| HSTO Histogen Inc. | M Exercise deriv | 2020-05-22 | 2020-05-27 | 65,000 | — | $0 | 0 | SEC↗ |
| HSTO Histogen Inc. | F Tax w/h | 2020-05-22 | 2020-05-27 | 31,428 | $0.56 | $17.6K | 39,572 | SEC↗ |
| HSTO Histogen Inc. | M Exercise | 2020-05-22 | 2020-05-27 | 65,000 | — | $0 | 71,000 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | D To issuer deriv | 2019-08-01 | 2019-08-01 | 150,000 | — | $0 | 0 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | D To issuer deriv | 2019-08-01 | 2019-08-01 | 400,000 | — | $0 | 0 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | A Award deriv | 2019-08-01 | 2019-08-01 | 650,000 | — | $0 | 650,000 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | D To issuer deriv | 2019-08-01 | 2019-08-01 | 350,000 | — | $0 | 0 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | D To issuer deriv | 2019-08-01 | 2019-08-01 | 50,000 | — | $0 | 0 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | D To issuer deriv | 2019-08-01 | 2019-08-01 | 172,500 | — | $0 | 0 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | D To issuer deriv | 2019-08-01 | 2019-08-01 | 37,500 | — | $0 | 0 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | D To issuer deriv | 2019-08-01 | 2019-08-01 | 20,000 | — | $0 | 0 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | D To issuer deriv | 2019-08-01 | 2019-08-01 | 120,000 | — | $0 | 0 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | A Award deriv | 2019-02-07 | 2019-02-11 | 350,000 | — | $0 | 350,000 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award deriv | 2018-06-11 | 2018-06-12 | 15,000 | — | $0 | 15,000 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award | 2018-06-11 | 2018-06-12 | 2,500 | — | $0 | 14,332 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | M Exercise deriv | 2018-05-04 | 2018-05-07 | 60,000 | — | $0 | 147,070 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | M Exercise | 2018-05-04 | 2018-05-07 | 60,000 | $0.99 | $59.4K | 60,000 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | M Exercise deriv | 2018-04-02 | 2018-04-04 | 10,000 | — | $0 | 0 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | M Exercise | 2018-04-02 | 2018-04-04 | 10,000 | $7.77 | $77.7K | 19,047 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | S Sale | 2018-04-02 | 2018-04-04 | 7,115 | $18.39 | $130.8K | 11,932 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | S Sale | 2018-04-02 | 2018-04-04 | 100 | $18.90 | $1.9K | 11,832 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | M Exercise deriv | 2018-03-01 | 2018-03-05 | 10,000 | — | $0 | 0 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | M Exercise deriv | 2018-03-01 | 2018-03-05 | 5,000 | — | $0 | 0 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | M Exercise | 2018-03-01 | 2018-03-05 | 10,000 | $5.03 | $50.3K | 18,480 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | M Exercise | 2018-03-01 | 2018-03-05 | 5,000 | $6.41 | $32.0K | 8,480 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | S Sale | 2018-03-01 | 2018-03-05 | 9,433 | $23.27 | $219.5K | 9,047 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | A Award deriv | 2018-02-04 | 2018-02-05 | 120,000 | — | $0 | 120,000 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | M Exercise deriv | 2018-02-01 | 2018-02-05 | 5,000 | — | $0 | 5,000 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | M Exercise deriv | 2018-02-01 | 2018-02-05 | 10,000 | — | $0 | 0 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | S Sale | 2018-02-01 | 2018-02-05 | 11,520 | $20.59 | $237.2K | 3,480 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | M Exercise | 2018-02-01 | 2018-02-05 | 10,000 | $10.17 | $101.7K | 15,000 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | M Exercise | 2018-02-01 | 2018-02-05 | 5,000 | $6.41 | $32.0K | 5,000 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award deriv | 2017-06-05 | 2017-06-07 | 10,000 | — | $0 | 10,000 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | A Award deriv | 2017-01-26 | 2017-02-01 | 172,500 | — | $0 | 172,500 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | M Exercise deriv | 2016-12-20 | 2016-12-22 | 36,363 | — | $0 | 0 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | M Exercise deriv | 2016-12-20 | 2016-12-22 | 5,051 | — | $0 | 207,070 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | M Exercise | 2016-12-20 | 2016-12-22 | 5,051 | $0.99 | $5.0K | 41,414 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | M Exercise | 2016-12-20 | 2016-12-22 | 36,363 | $1.24 | $45.1K | 36,363 | SEC↗ |
| SGMO SANGAMO BIOSCIENCES INC | A Award deriv | 2016-06-14 | 2016-06-15 | 10,000 | — | $0 | 10,000 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | A Award deriv | 2016-02-04 | 2016-02-08 | 37,500 | — | $0 | 37,500 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | A Award deriv | 2016-02-04 | 2016-02-08 | 187,500 | — | $0 | 187,500 | SEC↗ |
| SGMO SANGAMO BIOSCIENCES INC | M Exercise deriv | 2015-06-22 | 2015-06-24 | 10,000 | — | $0 | 10,000 | SEC↗ |
| SGMO SANGAMO BIOSCIENCES INC | M Exercise deriv | 2015-03-05 | 2015-03-06 | 10,000 | — | $0 | 0 | SEC↗ |
| SGMO SANGAMO BIOSCIENCES INC | S Sale | 2015-03-05 | 2015-03-06 | 6,501 | $18.30 | $119.0K | 12,270 | SEC↗ |
| SGMO SANGAMO BIOSCIENCES INC | M Exercise | 2015-03-05 | 2015-03-06 | 10,000 | $4.54 | $45.4K | 18,771 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | A Award deriv | 2015-02-23 | 2015-02-25 | 50,000 | — | $0 | 50,000 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | A Award deriv | 2015-02-23 | 2015-02-25 | 150,000 | — | $0 | 150,000 | SEC↗ |
| SGMO SANGAMO BIOSCIENCES INC | M Exercise deriv | 2014-12-11 | 2014-12-15 | 10,000 | — | $0 | 0 | SEC↗ |
| SGMO SANGAMO BIOSCIENCES INC | M Exercise | 2014-12-11 | 2014-12-15 | 10,000 | $4.10 | $41.0K | 35,069 | SEC↗ |
| SGMO SANGAMO BIOSCIENCES INC | S Sale | 2014-12-11 | 2014-12-15 | 6,354 | $15.00 | $95.3K | 28,715 | SEC↗ |
| SGMO SANGAMO BIOSCIENCES INC | M Exercise deriv | 2014-06-09 | 2014-06-11 | 5,834 | — | $0 | 0 | SEC↗ |
| SGMO SANGAMO BIOSCIENCES INC | M Exercise | 2014-06-09 | 2014-06-11 | 5,834 | $7.28 | $42.5K | 29,397 | SEC↗ |
| SGMO SANGAMO BIOSCIENCES INC | S Sale | 2014-06-09 | 2014-06-11 | 4,328 | $15.00 | $64.9K | 25,069 | SEC↗ |
| SGMO SANGAMO BIOSCIENCES INC | A Award deriv | 2014-04-21 | 2014-04-23 | 10,000 | — | $0 | 10,000 | SEC↗ |
| SGMO SANGAMO BIOSCIENCES INC | M Exercise deriv | 2014-03-14 | 2014-03-17 | 9,722 | — | $0 | 0 | SEC↗ |
| SGMO SANGAMO BIOSCIENCES INC | S Sale | 2014-03-14 | 2014-03-17 | 6,103 | $22.77 | $139.0K | 23,563 | SEC↗ |
| SGMO SANGAMO BIOSCIENCES INC | M Exercise | 2014-03-14 | 2014-03-17 | 9,722 | $3.87 | $37.6K | 29,666 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | A Award deriv | 2014-02-07 | 2014-02-11 | 400,000 | — | $0 | 400,000 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | C Conversion deriv | 2013-07-30 | 2013-08-01 | 786,417 | — | $0 | 0 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | J Other | 2013-07-30 | 2013-08-01 | 1,395 | $11.00 | $15.3K | 371,869 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | P Buy | 2013-07-30 | 2013-08-01 | 13,800 | $11.00 | $151.8K | 385,669 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | C Conversion | 2013-07-30 | 2013-08-01 | 95,323 | — | $0 | 370,474 | SEC↗ |
| SGMO SANGAMO BIOSCIENCES INC | A Award deriv | 2013-06-12 | 2013-06-14 | 10,000 | — | $0 | 10,000 | SEC↗ |
| SGMO SANGAMO BIOSCIENCES INC | A Award deriv | 2012-06-21 | 2012-06-25 | 10,000 | — | $0 | 10,000 | SEC↗ |